Artificial Intelligence3 years ago
Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
Innoforce Pharmaceuticals (“INF”), a biopharmaceutical innovation and partnership company, announced today the completion of a 625M CNY ($96M) Series A financing, which follows a 170M CNY ($24M) Pre-A financing completed in June...